Highlights from a wide ranging discussion on COVID-19 pandemic response from Kate Broderick, Chief Innovation Officer at Maravai LifeSciences, and Tom Madden, President & CEO at Acuitas Therapeutics.

Landkarte *** Europa | Image Credit: © beugdesign - Stock.adobe.com

Phasing Out COVID-19 Regulatory Flexibilities

By Cheryl Barton

August 2nd 2023

What impact will EMA’s decision to phase out COVID-19 regulatory flexibilities have on the pharma industry?

Europe Phases Out COVID-19 Flexible Regulations

By Susan Haigney

July 6th 2023

EMA, the European Commission, and HMAs are phasing out the flexible regulations put into place during the pandemic.

COVID-19 Vaccine, Nuvaxovid, Gains EU Approval

By Susan Haigney

July 6th 2023

Full Marketing Authorization has been granted for Novavax’s COVID-19 vaccine by the European Commission.

Combatting Future Viral Threats with Vaccine Advances

The COVID-19 pandemic has led to many changes in how pharmaceutical companies develop vaccines.

Visit Now

Combatting Future Viral Threats with Vaccine Advances; Image: filin174 - Stock.adobe.com

...

23 24 25 26 27

About Us

Advertise

Editorial Info

Editorial Advisory Board

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777